These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36206167)

  • 1. COVID-19 update: Bivalent Pfizer and Moderna COVID-19 vaccines for booster immunization.
    Med Lett Drugs Ther; 2022 Oct; 64(1660):159-160. PubMed ID: 36206167
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 update: Pfizer bivalent vaccine booster dose for children 6 months to 4 years old.
    Med Lett Drugs Ther; 2023 Apr; 65(1674):63-64. PubMed ID: 37039615
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 update:Booster dose of the Pfizer vaccine for children 5-11 years old.
    Med Lett Drugs Ther; 2022 Jun; 64(1652):94. PubMed ID: 35657366
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 updates: Moderna COVID-19 vaccine (Spikevax) gains full licensure.
    Med Lett Drugs Ther; 2022 Feb; 64(1644):32. PubMed ID: 35175715
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 update: Novavax vaccine authorized for booster immunization.
    Med Lett Drugs Ther; 2022 Oct; 64(1662):e1-e2. PubMed ID: 36383772
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021.
    Bajema KL; Dahl RM; Evener SL; Prill MM; Rodriguez-Barradas MC; Marconi VC; Beenhouwer DO; Holodniy M; Lucero-Obusan C; Brown ST; Tremarelli M; Epperson M; Mills L; Park SH; Rivera-Dominguez G; Morones RG; Ahmadi-Izadi G; Deovic R; Mendoza C; Jeong C; Schrag SJ; Meites E; Hall AJ; Kobayashi M; McMorrow M; Verani JR; Thornburg NJ; Surie D; ; ;
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1700-1705. PubMed ID: 34882654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021.
    Tenforde MW; Patel MM; Gaglani M; Ginde AA; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Duggal A; Wilson JG; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Botros M; Lauring AS; Shapiro NI; Halasa N; Chappell JD; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Naioti EA; Adams K; Lewis NM; Surie D; McMorrow ML; Self WH;
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):118-124. PubMed ID: 35085218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 update: Bivalent Pfizer and Moderna vaccines authorized for children ≥6 months old.
    Med Lett Drugs Ther; 2022 Dec; 64(1665):e209-e210. PubMed ID: 36541943
    [No Abstract]   [Full Text] [Related]  

  • 9. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
    Fleming-Dutra KE; Wallace M; Moulia DL; Twentyman E; Roper LE; Hall E; Link-Gelles R; Godfrey M; Woodworth KR; Anderson TC; Rubis AB; Shanley E; Jones JM; Morgan RL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley M; Meyer S; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(26):859-868. PubMed ID: 35771731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Booster dose of the Pfizer/BioNTech COVID-19 vaccine (Comirnaty).
    Med Lett Drugs Ther; 2021 Oct; 63(1635):161-162. PubMed ID: 35050241
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 update: Pfizer/BioNTech and Moderna vaccines authorized for children ≥6 months old.
    Med Lett Drugs Ther; 2022 Jul; 64(1654):110-112. PubMed ID: 35802844
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
    Abu-Raddad LJ; Chemaitelly H; Ayoub HH; AlMukdad S; Yassine HM; Al-Khatib HA; Smatti MK; Tang P; Hasan MR; Coyle P; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R
    N Engl J Med; 2022 May; 386(19):1804-1816. PubMed ID: 35263534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 updates: Second booster vaccine dose for older and immunocompromised persons.
    Med Lett Drugs Ther; 2022 Apr; 64(1648):63-64. PubMed ID: 35436777
    [No Abstract]   [Full Text] [Related]  

  • 14. Booster doses of COVID-19 vaccines.
    Med Lett Drugs Ther; 2021 Nov; 63(1638):186-188. PubMed ID: 35085215
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
    Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Blanc PG; Gwira Baumblatt JA; Woo EJ; Gee J; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):249-254. PubMed ID: 35176008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic stroke after COVID-19 bivalent vaccine administration in patients aged 65 years and older: analysis of nation-wide patient electronic health records in the United States.
    Gorenflo MP; Davis PB; Kaelber DC; Xu R
    medRxiv; 2023 Feb; ():. PubMed ID: 36824915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study.
    Andersson NW; Thiesson EM; Laursen MV; Mogensen SH; Kjær J; Hviid A
    BMJ; 2022 Jul; 378():e070483. PubMed ID: 35831006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022.
    Wallace M; Moulia D; Blain AE; Ricketts EK; Minhaj FS; Link-Gelles R; Curran KG; Hadler SC; Asif A; Godfrey M; Hall E; Fiore A; Meyer S; Su JR; Weintraub E; Oster ME; Shimabukuro TT; Campos-Outcalt D; Morgan RL; Bell BP; Brooks O; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(11):416-421. PubMed ID: 35298454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In brief: Booster doses of mRNA-based COVID-19 vaccines for all adults.
    Med Lett Drugs Ther; 2021 Dec; 63(1640):201-202. PubMed ID: 35100238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.